Citadel Advisors »

Sutro Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $371k 32k 11.57

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Kynam Capital Management
Millennium Management
Vanguard Group
Acadian Asset Management
Velan Capital Investment Management
Vestal Point Capital
Balyasny Asset Management
Samsara BioCapital
Adage Capital Partners GP
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies

View all funds holding Sutro Biopharma